πŸ‡ΊπŸ‡Έ FDA
Patent

US 8858925

Pegylated fibrinogen precursor molecule

granted A61KA61K38/363A61K38/39

Quick answer

US patent 8858925 (Pegylated fibrinogen precursor molecule) held by REGENTIS BIOMATERIALS LTD. expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENTIS BIOMATERIALS LTD.
Grant date
Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/363, A61K38/39, A61K38/45, A61K47/60